OMRON Healthcare has supported the initiative since its inception, contributing to screening efforts in around 120 countries and donating approximately 33,000 blood pressure monitors to date. The 2026 campaign will run from May to July, focusing on large-scale screening events and public education on blood pressure monitoring, lifestyle modification, and cardiovascular risk reduction.

Professor Neil R. Poulter, Chief Investigator and Chair of Trustees of May Measurement Month, said: “Hypertension (high blood pressure) is the leading risk factor for cardiovascular diseases, including stroke, heart attacks, heart failure, and the potentially life-threatening arrhythmia atrial fibrillation. By donating blood pressure monitors capable of detecting probable atrial fibrillation, this initiative can enhance the early detection and treatment of hypertension and atrial fibrillation, ultimately helping to save more lives around the world from cardiovascular diseases.”

Ayumu Okada, President and CEO of OMRON Healthcare added: “Since the launch of our first home blood pressure monitor in 1973, we have worked alongside healthcare professionals to promote the importance of blood pressure monitoring and improve access to home measurement. The goals of May Measurement Month align closely with our own Going for ZERO vision, which aims to eliminate cerebro-cardiovascular events worldwide, and we will continue to collaborate with May Measurement Month to improve global cardiovascular health outcomes through the further expansion of this important initiative.”